0001582313 2026-04-13 2026-04-13 0001582313 1 2026-04-13 2026-04-13 pure shares iso4217:USD false 0001582313 N/A N/A EX-FILING FEES S-8 S-8 Xenon Pharmaceuticals Inc. Equity Common Shares, no par value per share true 275000 58.4 16060000 0.0001381 2217.89 16060000 2217.89 0 2217.89 <div class="item-list-element-wrapper" style="margin-left:2.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;margin-right:1.333%;min-width:2.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:2.602798752462246%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities Act</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">”), this Registration Statement shall also cover any additional common shares of the Registrant that become issuable under the Amended and Restated 2025 Inducement Equity Incentive Plan (the “</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amended and Restated 2025 Plan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">”) by reason of any share dividend, share split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant’s outstanding common shares.</span></div></div>